First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy
Clinical trial NCT04568174 · TERMINATED
Trial details
- NCT number
- NCT04568174
- Sponsor
- Polyneuron Pharmaceuticals AG
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-17
- Primary completion
- 2021-09-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.